Navigation Links
Cortex Area Thinner in Youth with Alzheimers-Related Gene

cations/UnravelingTheMystery/Part1/Hallmarks.htm">http://www.nia.nih.gov/Alzheimers/Publications/UnravelingTheMystery/Part1/Hallmarks.htm) characteristic of the disorder.

Previous studies had also implicated in Alzheimers one of three versions of a gene that produces ApoE. The ApoE4 variant occurs in 10-25 percent of the general population, but in 40 percent of late-onset Alzheimers patients. The strongest genetic risk factor for the disease discovered to date, ApoE4 has been linked to altered brain activity in adults and impaired neuronal development.

Shaw and colleagues suspected that youth with ApoE4 would have a thinner entorhinal cortex. To confirm this, they compared the MRI (magnetic resonance imaging) scans of 239 healthy children and teens with their ApoE gene types. Many were re-scanned as they grew up to see if there was any ongoing thinning process traceable to ApoE4.

Each individual inherits two copies of the ApoE gene, one from each parent. Youth with at least one copy of the relatively rare ApoE2 variant — which may confer a protective effect against developing Alzheimers — showed the thickest entorhinal cortex. This was the first evidence that the ApoE2 version, which is carried by 5-10 percent of the population, affects brain structure, say the researchers. Youth with two copies of ApoE3, the most common version (65-85 percent prevalence), had intermediate cortex thickness. Those with one or two copies of ApoE4 had the thinnest entorhinal cortex.

ApoE4 gene type also predicted thinning of two other brain regions (medial temporal and posterior orbitofrontal areas) affected early in Alzheimers disease, which, like the entorhinal cortex, are involved in learning and memory. The pattern of changes resembled that seen in early Alzheimers, but to a far lesser degree. For example, the entorhinal cortex thinning seen in Alzheimers disease is about 10-fold greater than in the youth with ApoE4.

Although they
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cortex Area Thinner Youth with Alzheimers Related Gene
(Date:3/3/2015)... HOUSTON , March 3, 2015  Cyberonics, Inc. ... medical devices for the treatment and management of epilepsy, ... Healthcare Conference on Wednesday, March 11, 2015, in ... , Cyberonics, President and Chief Executive Officer, will speak ... conducted in a fireside chat format, and no formal ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., ... cell-derived islet replacement therapy for the treatment of diabetes ... Eugene Brandon , Director of Strategic Relations and ... summit showcases the latest in type 1 diabetes management ... are as follows: , , , Title:   ...
(Date:3/3/2015)... , March 3, 2015  Cannabis Science, Inc. (OTCQB: ... cannabis-based medicine, today announced two important developments: It launched ... global product launches, and CEO Raymond C. Dabney ... HR Examiner. In the article, Dabney answers ... leading a company in an industry that is too ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5
... announced that Xeomin ® (incobotulinumtoxinA), a new botulinum toxin ... (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN ... on July 30, 2010. XEOMIN is a botulinum ... is FDA-approved for the treatment of adults with cervical dystonia, ...
... 5 Lixte Biotechnology Holdings (OTC: ... Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), ... Cancer Institute (NCI), National Institutes of Health (NIH), ... collaboration with Lixte Biotechnology Holdings, Inc. for clinical ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 2Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 3Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 4Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 5Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 6Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 2Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... is estimated to grow from $1,224.6 million ... 6.71% between 2014 and 2019. , Browse ... delivery network market for an analysis of ... of various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... Vancouver, BC (PRWEB) March 03, 2015 ... iData Research ( http://www.idataresearch.com ), market saturation has ... of care in the United States. Unit sales ... continue to increase as facilities replace older systems, ... neurosurgery navigation system market is very much a ...
(Date:3/3/2015)... Celestix Networks, the leading provider of ... global availability of Celestix Cloud Edge Security Appliance ... deployed platform for DirectAccess and remote access roles ... release enables organizations to manage the Windows® Server ... HTML 5 web interface called Comet 2.0. ...
Breaking Medicine News(10 mins):Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... our stomach may reduce the protective effects of antioxidants ... Glasgow found that in the presence of lipid the ... component of vitamin C), to protect against the generation ... than when no lipids are present. “Our results illustrate ...
... the blues? There’s nothing like getting down and dirty say ... ,The study led by Dr. Chris Lowry ... Mycobacterium vaccae, can actually replicate the effects of anti- depressant ... of lung cancer patients who were treated with the ...
... at those simple, inexpensive, often boisterous bistros that made Paris ... ,The reason is that a number of young chefs, ... to exercise their talents in the casual atmosphere of a ... of vying for a Michelin star. ,As a ...
... California, San Diego (UCSD) School of Medicine have discovered ... with increased clotting of the blood, which has previously ... published in the March issue of CHEST, the official ... ,'In previous work, we have found that sleep ...
... be hailed as a leprosy-free zone by health administrators worldwide. ... more are suffering// from the terrifying disease. ,But ... point out. And the stigma the disease carries with it ... an ancient, much feared disease. But although it is infectious ...
... showing actors blowing glorious rings of smoke or village ... reach for those below 18 years//. ,An ... against tobacco consumption has suggested that films showing smoking ... ,Public Health Foundation of India (PHFI), an autonomous ...
Cached Medicine News:Health News:Be Happy- Get On Your Knees And Play In The Mud 2Health News:'Bistronomy' is Conquering Dining in Paris 2Health News:'Bistronomy' is Conquering Dining in Paris 3Health News:Indian Films With Smoking Scenes may Get 'A' Certificate 2
SURGISPIKE™ Single Use 5 mm Trocar. , ,Bladed Trocars are devices that contain a metal blade to gain access to the abdominal cavity....
... The complete line of Surgical Access ... ,The OnePort™ trocar system is actually ... be versatile, operationally flexible and clinically adaptive ... offering options in disposability and bladed or ...
... of Surgical Access ...unlike any trocar system ... system is actually four systems in one ... and clinically adaptive to all of your ... and bladed or dilating tip styles, OnePort™ ...
... FPK01 Thoracic Trocar Pak ... 15mm flexible sleeves and (1) ... ,FPK02 Thoracic Trocar Pak ... 15mm flexible sleeves., ,FPK03 ...
Medicine Products: